Development of CpG‐Depleted <i>CFTR</i> Plasmid‐Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Disease

Authors

Publication Details

Journal
Apollo (University of Cambridge)
Published
2025-10-12
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of CpG‐Depleted CFTR Plasmid‐Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Disease

Zhonglei He, Bei Qiu, Maryann Lorino, Irene Lara‐Sáez et al.
Apollo (University of Cambridge)
Cystic Fibrosis Research Advances
article

Development of CpG‐Depleted CFTR Plasmid‐Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Disease

Zhonglei He, Bei Qiu, Maryann Lorino, Irene Lara‐Sáez, Xianqing Wang, Yinghao Li, Wenxin Wang
article en

Abstract

No abstract available for this paper.
Apollo (University of Cambridge)
Openalex Percentile: Top 23%
Cystic Fibrosis Research Advances
Open Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of CpG‐Depleted <i>CFTR</i> Plasmid‐Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Disease — Zhonglei He, Bei Qiu, et al. · Apollo (University of Cambridge) (2025) | TGRS Research Map | TGRS